Cargando…
Response to Letter to the Editor from Sukor et al.: “Evaluation and Treatment of Amiodarone-induced Thyroid Disorders”
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8208675/ https://www.ncbi.nlm.nih.gov/pubmed/33624808 http://dx.doi.org/10.1210/clinem/dgab105 |
_version_ | 1783708968710832128 |
---|---|
author | Ylli, Dorina Wartofsky, Leonard Burman, Kenneth D |
author_facet | Ylli, Dorina Wartofsky, Leonard Burman, Kenneth D |
author_sort | Ylli, Dorina |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8208675 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-82086752021-06-21 Response to Letter to the Editor from Sukor et al.: “Evaluation and Treatment of Amiodarone-induced Thyroid Disorders” Ylli, Dorina Wartofsky, Leonard Burman, Kenneth D J Clin Endocrinol Metab Letters to the Editor Responses Oxford University Press 2021-02-24 /pmc/articles/PMC8208675/ /pubmed/33624808 http://dx.doi.org/10.1210/clinem/dgab105 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Letters to the Editor Responses Ylli, Dorina Wartofsky, Leonard Burman, Kenneth D Response to Letter to the Editor from Sukor et al.: “Evaluation and Treatment of Amiodarone-induced Thyroid Disorders” |
title | Response to Letter to the Editor from Sukor et al.: “Evaluation and Treatment of Amiodarone-induced Thyroid Disorders” |
title_full | Response to Letter to the Editor from Sukor et al.: “Evaluation and Treatment of Amiodarone-induced Thyroid Disorders” |
title_fullStr | Response to Letter to the Editor from Sukor et al.: “Evaluation and Treatment of Amiodarone-induced Thyroid Disorders” |
title_full_unstemmed | Response to Letter to the Editor from Sukor et al.: “Evaluation and Treatment of Amiodarone-induced Thyroid Disorders” |
title_short | Response to Letter to the Editor from Sukor et al.: “Evaluation and Treatment of Amiodarone-induced Thyroid Disorders” |
title_sort | response to letter to the editor from sukor et al.: “evaluation and treatment of amiodarone-induced thyroid disorders” |
topic | Letters to the Editor Responses |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8208675/ https://www.ncbi.nlm.nih.gov/pubmed/33624808 http://dx.doi.org/10.1210/clinem/dgab105 |
work_keys_str_mv | AT yllidorina responsetolettertotheeditorfromsukoretalevaluationandtreatmentofamiodaroneinducedthyroiddisorders AT wartofskyleonard responsetolettertotheeditorfromsukoretalevaluationandtreatmentofamiodaroneinducedthyroiddisorders AT burmankennethd responsetolettertotheeditorfromsukoretalevaluationandtreatmentofamiodaroneinducedthyroiddisorders |